Parkinson's Disease Clinical Trials

Showing 841-860 of 890 trials

A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

NCT01229332

A cross-over study, where ND0611 or placebo will be tested on top of 3 different LD/CD dosage forms. Safety and tolerability, pharmacokinetic profile of levodopa and carbidopa and the potential clinical effect of ND0611 will be explored in subjects with PD and motor fluctuations.

Parkinson's Disease

NeuroDerm Ltd.24 participantsStarted Jan 2011

Jerusalem, Israel

COMPLETEDPHASE1/PHASE2

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

NCT00407212

This study will investigate the effect of TCH346 compared to placebo in delaying the need for symptomatic treatment with dopaminergic agents

Parkinson's Disease

Novartis301 participantsStarted Jan 2002

Phoenix, Arizona, United States • Berkley, California, United States • Fountain Valley, California, United States +42 more locations

A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

A Study of Three Doses of TCH346 in Patients With Early Parkinson's Disease to Evaluate Safety and Efficacy

Related Searches

Mesenchymal Stem Cells Transplantation to Patients With Parkinson's Disease

The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

Balance Training in Parkinson's Disease Using the Wii Balance Board

Perioperative Treatment of Parkinsonian Patients With Parenteral Amantadine

Study of the Role of G72 in Amyotrophic Lateral Sclerosis: Biomarker Discovery and Mechanism Investigation

Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)

Development of a Fall Prevention and Fall Detection System for Ambulatory Rehabilitation of Parkinson's Patients

Ramelteon (ROZEREM) in the Treatment of Sleep Disturbances Associated With Parkinson's Disease

Biofeedback-based Motor Learning to Ameliorate Freezing of Gait

A Survey Study to See if Patients Diagnosed With Parkinson's Disease Have Higher Incidence of Melanoma

Pilot Study of Maintenance Therapy With Intravenous AMANTADINE

Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

An Open Label SLV308 Safety Extension to Study S308.3.002 in Patients With Parkinson's Disease Experiencing Motor Fluctuations.

Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease

Effects of Chocolate on Motor Symptoms of Parkinson's Disease

Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa